Showing results (2631-2640 of 6,418) with videos related to
Sort By:
Pageof 642
Clinical Cardiology|May 4, 2011
Drug-eluting stents vs. intracoronary brachytherapy for in-stent restenosis: a meta-analysisYong-Guang Lu, Yan-Mei Chen, Lang Li, et al.Clinical Cardiology|May 4, 2011
Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patientsDebasish Banerjee, Alejandro Recio-Mayoral, Nihil Chitalia, et al.Clinical Cardiology|April 5, 2011
Anomalous origin of the left coronary artery from the pulmonary artery in adults: a comprehensive review of 151 adult cases and a new diagnosis in a 53-year-old womanJames M Yau, Rajiv Singh, Ethan J Halpern, et al.Clinical Cardiology|November 19, 2011
Clinical impact of off-label cardiac resynchronization therapy in end-stage heart failure patients on continuous intravenous inotropeMasahiko Hara, Hiroya Mizuno, Isamu Mizote, et al.Clinical Cardiology|November 8, 2011
Use of Angio-Seal closure device when the arteriotomy is above or below the common femoral arteryRahul Bose, Jeffrey M SchusslerClinical Cardiology|November 16, 2011
Relationship between cardiovascular disease knowledge and race/ethnicity, education, and weight statusElsa-Grace V Giardina, Lorraine Mull, Robert R Sciacca, et al.Clinical Cardiology|November 16, 2011
Differential effect of β-blockers for heart rate control in coronary artery diseaseAlberto Cordero, Vicente Bertomeu-González, Pilar Mazón, et al.Clinical Cardiology|September 10, 2011
Impact of diabetes mellitus on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) educational programGiuliano Tocci, Andrea Ferrucci, Pietro Guida, et al.Clinical Cardiology|April 1, 1990
Current perspectives in hypertrophic cardiomyopathy: diagnosis, clinical management, and prevention of disability and sudden cardiac deathT W von Dohlen, M J FrankClinical Cardiology|June 1, 1990
Future directions in plasminogen activator therapyC Bode, M S Runge, E HaberPageof 642